What is Royalty Pharma's revenue?

Royalty Pharma (RPRX) generated $2.4B in revenue over the trailing twelve months, up 7.8% year over year.

Is Royalty Pharma profitable?

Royalty Pharma reported $827.3M in net income over the trailing twelve months, a 33.9% net margin.

What is Royalty Pharma's earnings per share?

Royalty Pharma's diluted EPS over the trailing twelve months is $1.91.

Where does Royalty Pharma's income statement data come from?

Every line is extracted from Royalty Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Royalty Pharma RPRX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$2.44B+2.6%	$2.38B+1.2%	$2.35B+1.9%	$2.31B+1.8%	$2.26B0.0%
Research and development	$441.29M-2.4%	$452M+12.4%	$402M+14.2%	$352M+577%	$52M+2,500%
General and administrative	$622.27M+8.5%	$573.48M+20.3%	$476.8M+15.0%	$414.79M+43.2%	$289.72M+22.4%
Total costs & expenses	$852.15M+4.1%	$818.67M+0.2%	$817.19M+75.9%	$464.67M+27.9%	$363.45M-62.6%
Operating income	$1.59B+1.9%	$1.56B+1.8%	$1.53B-16.7%	$1.84B-3.1%	$1.9B+47.0%
Operating margin	65.1%-0.5pp	65.6%+0.4pp	65.2%-14.6pp	79.8%-4.1pp	83.9%+26.8pp
Interest expense	$336.13M+9.3%	$307.66M+10.2%	$279.25M+4.9%	$266.2M+8.0%	$246.54M+9.3%
Other income (expense), net	-$229.36M+2.1%	-$234.33M—	——	——	——
Income before income taxes	$1.36B+2.6%	$1.33B+1.7%	$1.3B-21.7%	$1.67B-5.9%	$1.77B+33.0%
Income tax expense	$0—	$0—	$0—	$0—	$0—
Net income	$827.29M+7.2%	$771.95M+0.8%	$765.96M-25.0%	$1.02B-6.6%	$1.09B+27.3%
Net margin	33.9%+1.4pp	32.5%-0.1pp	32.6%-11.7pp	44.3%-4.0pp	48.3%+10.4pp
Diluted earnings per share	$1.91+6.7%	$1.79+1.7%	$1.76-23.5%	$2.30-6.5%	$2.46+28.1%
EBIT	$1.59B+1.9%	$1.56B+1.8%	$1.53B-16.7%	$1.84B-3.1%	$1.9B+47.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Royalty Pharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Royalty Pharma's revenue?: Royalty Pharma (RPRX) generated $2.4B in revenue over the trailing twelve months, up 7.8% year over year.
Is Royalty Pharma profitable?: Royalty Pharma reported $827.3M in net income over the trailing twelve months, a 33.9% net margin.
What is Royalty Pharma's earnings per share?: Royalty Pharma's diluted EPS over the trailing twelve months is $1.91.
Where does Royalty Pharma's income statement data come from?: Every line is extracted from Royalty Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.